Entity type
Individual
Filer Snapshot
Tobin Schilke
CIK 0001678984. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
2
Latest filing
03 Jan 2024
Industry
n/a
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: Forms 3/4/5 owner position for CRNX. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
—
No recent parsed 13D/G stake row for this CIK.
Browse 13D/GInsider / owner context
CRNX
03 Mar 2026 · $3.1M
Open owner pageSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Forms 3/4/5
View Source Filing
4 filed on 03 Jan 2024 for CIK 0001678984.
- Ownership signals
-
SEC value by filing type
Compare filing types separately; 13F, 13D/G, and Forms 3/4/5 are different evidence sources.
Forms 3/4/5 positions$3.1MReporting-owner positions with enough data to estimate value.
Estimated Forms 3/4/5 position value
$3.1M
Estimated only when owner filings include enough share and price data.
Largest linked SEC positions
Largest issuer positions found across parsed 13F, 13D/G, and Forms 3/4/5 data.
CRNXHow to read these SEC values
- Read each filing type on its own: 13F portfolios, 13D/G large stakes, and Forms 3/4/5 owner positions answer different questions.
- Open the linked research paths when you need to verify the exact SEC filing behind a value.
- Business address
- Crinetics Pharmaceuticals, Inc., 6055 Lusk Boulevard, San Diego, CA, 92121
Ownership signals
1 signal
Identity
1 identity field
Filer intelligence
What SEC filings say about Tobin Schilke
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- Forms 3/4/5 show insider context for CRNX worth $3.1M.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
Forms 3/4/5 insider context
CRNX
03 Mar 2026 · Chief Financial Officer
RVNC
04 Feb 2025 · CFO
Latest update
What changed recently for Tobin Schilke
Latest ownership report period: 03 Mar 2026. Open the source-backed page to inspect the fresh filing or facts context.
Update date
04 Mar 2026
Page type
Ownership filings
Latest period
03 Mar 2026
Ownership context was refreshed from SEC Forms 3/4/5 filed on 04 Mar 2026.
SEC filing record
CIK 0001678984 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
2
First seen
15 Aug 2023
Latest filing
03 Jan 2024
Entity
Individual
Observed form types
4
CIK-linked evidence first
Latest Filings
Showing the latest 2 of 2 SEC filings for Tobin Schilke.
4
4 filing
- Filing date
- 03 Jan 2024
- Reporting date
- 31 Dec 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 15 Aug 2023
- Reporting date
- 11 Aug 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing